Smith Graham & Co Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phibro Animal Health
PAHC
|
+$9.81M |
| 2 |
Northwest Natural Holdings
NWN
|
+$8.84M |
| 3 |
Prestige Consumer Healthcare
PBH
|
+$8.49M |
| 4 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$5.96M |
| 5 |
Plexus
PLXS
|
+$4.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$14.8M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
+$11.5M |
| 3 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$6.26M |
| 4 |
Ziff Davis
ZD
|
+$5.15M |
| 5 |
Lincoln National
LNC
|
+$4.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Consumer Discretionary | 19.31% |
| 3 | Industrials | 16.07% |
| 4 | Financials | 15.63% |
| 5 | Healthcare | 13.71% |
Similar funds
Smith Graham & Co Investment Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Smith Graham & Co Investment Advisors held 146 positions worth $1.23B, up 13% from $1.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Smith Graham & Co Investment Advisors withdrew a net $80.2M in Q1 2021, closing 5 positions and reducing 123 holdings. Its most notable exit was Magellan Health Services, Inc., an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Smith Graham & Co Investment Advisors opened a new position in Phibro Animal Health worth $10.6M.
- Smith Graham & Co Investment Advisors's largest Q1 2021 buy was Phibro Animal Health: 434,267 shares worth $10.6M.
- Smith Graham & Co Investment Advisors added most to Eagle Pharmaceuticals, Inc. in Q1 2021, an estimated $5.96M increase.
- Smith Graham & Co Investment Advisors's biggest Q1 2021 reduction was Ziff Davis, cutting an estimated $5.15M.
- Smith Graham & Co Investment Advisors fully exited Magellan Health Services, Inc. in Q1 2021, selling an estimated $14.8M.
- Smith Graham & Co Investment Advisors's ten largest holdings make up 17% of its $1.23B portfolio in Q1 2021.
- Smith Graham & Co Investment Advisors opened 5 new positions and closed 5 in Q1 2021.
- Smith Graham & Co Investment Advisors's portfolio value rose 13% quarter-over-quarter to $1.23B.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.